Fire-district
Madison Fire Department
Madison Fire Department (Madison, WI) carries 42 drugs across 141 dose entries in its current published protocol, effective 2023-04-27.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses42
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 4 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | page 5 |
| Asthma / bronchospasm | peds | 2.5–5 mg | NEB | not captured | standing | page 5 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 6 |
| VF / pulseless VT | adult | 300 mg | IV | not captured | standing | page 6 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | page 6 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 162–324 mg | PO | not captured | standing | page 7 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV/IM | not captured | standing | page 8 |
| Bradycardia | peds | 0.02 mg/kg | IV/IM | not captured | standing | page 8 |
| Other | adult | 2 mg | IV/IO | not captured | standing | page 8 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | page 8 |
| Other | peds | 0.05 mg/kg | IM | not captured | standing | page 8 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 500–1000 mg | IV/IO | not captured | standing | page 9 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 9 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 9 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 9 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 9 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4–10 mg | IV/IM | not captured | standing | page 10 |
| Other | peds | 0.6 mg/kg | IV/IM | not captured | standing | page 10 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5–25 g | IV | not captured | standing | page 11 |
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 11 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | page 11 |
| Hypoglycemia | peds | 2.5 mL/kg | IV/IO | not captured | standing | page 11 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | page 12 |
| Seizure | adult | 5–10 mg | IV | not captured | standing | page 12 |
| Seizure | peds | 0.2 mg/kg | IV | not captured | standing | page 12 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 12 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 13 |
| Other | adult | 5–15 mg | IV | not captured | standing | page 13 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 14 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 14 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 15 |
| Other | peds | 2–20 mcg/kg | IV/IO | not captured | standing | page 15 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1–0.5 mg | IM | not captured | standing | page 16 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 16 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 16 |
| Other | peds | 5 mL | NEB | not captured | standing | page 16 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 17 |
| RSI induction | peds | 0.3 mg/kg | IV | not captured | standing | page 17 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–100 mcg | IV/IO/IM | not captured | standing | page 17 |
| Other | peds | 0.5–1 mcg/kg | IV/IO/IM | not captured | standing | page 17 |
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM | not captured | standing | page 17 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV/IO/IM | not captured | standing | page 17 |
Flumazenil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2 mg | IV | not captured | standing | page 18 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.5–1 mg/kg | IV | not captured | standing | page 19 |
| CHF / pulmonary edema | adult | 0.5–1 mg/kg | IV | not captured | standing | page 19 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 19 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 19 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 19 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 19 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5–1 mg | IV/IO/IM | not captured | standing | page 19 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5–1 mg | IV/IO/IM | not captured | standing | page 19 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | page 19 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 19 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125–250 mg | IV/IO/IM | not captured | standing | page 20 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 20 |
| Asthma / bronchospasm | adult | 125–250 mg | IV/IO/IM | not captured | standing | page 20 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 20 |
| COPD | adult | 125–250 mg | IV/IO/IM | not captured | standing | page 20 |
| COPD | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 20 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | page 21 |
| Asthma / bronchospasm | peds | 500 mcg | NEB | not captured | standing | page 21 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg/kg | IV | not captured | standing | page 22 |
| Other | peds | 0.5–1 mg/kg | IV | not captured | standing | page 22 |
| RSI induction | adult | 2 mg/kg | IV | not captured | standing | page 22 |
| RSI induction | peds | 2 mg/kg | IV | not captured | standing | page 22 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 30 mg | IV | not captured | standing | page 23 |
| Severe pain | adult | 60 mg | IM | not captured | standing | page 23 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 24 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV | not captured | standing | page 25 |
| Cardiac arrest | peds | 1 mg/kg | IV | not captured | standing | page 25 |
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | page 25 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 25 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.02–0.06 mg/kg | IV | not captured | standing | page 26 |
| Procedural sedation | peds | 0.02–0.06 mg/kg | IV | not captured | standing | page 26 |
| Status epilepticus | adult | 0.05–0.1 mg/kg | IV | not captured | standing | page 26 |
| Status epilepticus | peds | 0.05–0.1 mg/kg | IV | not captured | standing | page 26 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4–6 g | IV/IO | not captured | standing | page 27 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 27 |
| Other | adult | 2–4 g | IV/IO | not captured | standing | page 27 |
| Other | adult | 2–4 g | IV/IO | not captured | standing | page 27 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 27 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125–250 mg | IV/IO/IM | not captured | standing | page 20 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 20 |
| Asthma / bronchospasm | adult | 125–250 mg | IV/IO/IM | not captured | standing | page 20 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 20 |
| COPD | adult | 125–250 mg | IV/IO/IM | not captured | standing | page 20 |
| COPD | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 20 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2–0.3 mg/kg | IV/IO/IM | not captured | standing | page 28 |
| Other | adult | 2–2.5 mg | IV/IO/IM | not captured | standing | page 28 |
| Other | peds | 0.2–0.3 mg/kg | IV/IO/IM | not captured | standing | page 28 |
| Seizure | adult | 2–5 mg | IV/IO/IM | not captured | standing | page 28 |
| Seizure | peds | 0.2–0.5 mg/kg | IV/IO/IM | not captured | standing | page 28 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–5 mg | IV/IO/IM | not captured | standing | page 29 |
| Severe pain | adult | 2–5 mg | IV/IO/IM | not captured | standing | page 29 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 29 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4–2 mg | IV/IM/SQ | not captured | standing | page 29 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | page 30 |
| Other | peds | 1–5 mcg/kg | IV | not captured | standing | page 30 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–20 mcg | IV | not captured | standing | page 31 |
| Other | peds | 0.1–2 mcg/kg | IV | not captured | standing | page 31 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IM | not captured | standing | page 31 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 31 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 20 – 40 milliunits/min | IV | not captured | standing | page 32 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12.5 mg | IV | not captured | standing | page 33 |
| Other | adult | 25 mg | IM | not captured | standing | page 33 |
| Other | peds | 0.25–0.5 mg/kg | IV | not captured | standing | page 33 |
| Other | peds | 0.25–0.5 mg/kg | IM | not captured | standing | page 33 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 11.25 mg | NEB | not captured | standing | page 34 |
| Asthma / bronchospasm | peds | 11.25 mg | NEB | not captured | standing | page 34 |
| Croup | adult | 11.25 mg | NEB | not captured | standing | page 34 |
| Croup | peds | 11.25 mg | NEB | not captured | standing | page 34 |
| Other | adult | 11.25 mg | NEB | not captured | standing | page 34 |
| Other | peds | 11.25 mg | NEB | not captured | standing | page 34 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | page 35 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 35 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mEq/kg | IV | not captured | standing | page 36 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 36 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 36 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg/kg | IV | not captured | standing | page 37 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 37 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 37 |
| Other | peds | 2 mg/kg | IV | not captured | standing | page 37 |
| Other | peds | 2 mg/kg | IV | not captured | standing | page 37 |
| Other | peds | 2 mg/kg | IV | not captured | standing | page 37 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Alcohol withdrawal | adult | 100 mg | IV/IM | not captured | standing | page 38 |
| Alcohol withdrawal | peds | 10–25 mg | IV/IM | not captured | standing | page 38 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 38 |
| Other | peds | 10–25 mg | IV/IM | not captured | standing | page 38 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 39 |
| Obstetric hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 39 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 39 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 39 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 39 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 39 |